Deaths from acute respiratory distress syndrome (ARDS) and sepsis spiked in the US during the COVID pandemic, and subsequently declined, according to new data presented at the American College of ...

UCSF study shows that aging connective tissue in the lungs brings on a catastrophic immune response in older people.

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For patients with refractory acute respiratory distress syndrome (ARDS) due to COVID-19 infections, ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

New research highlights the impact of ageing-related inflammation, especially due to immune cells marked by the GZMK gene, first seen in people affected by severe COVID. View on euronews ...

InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress. The European Commission granted ...

Long COVID symptoms persist in over half of HCWs nearly 4 years after ancestral SARS-CoV-2 infection, despite a reduced overall burden.